Reporting

Evonik has published its quarterly report Q1 2023 on May 9, 2023. You can access further information here.

... MORE

Evonik strengthens competitiveness of its Animal Nutrition business

Evonik is transforming the operating model of its Animal Nutrition business to further increase its customer focus, ensure competitiveness and enable further profitable growth. ... MORE

Investor Relations

Annual shareholders’ meeting 2023

The Annual Shareholders‘ Meeting of Evonik Industries AG will place on May 31, 2023. Detailed information are available here. ... MORE

Information about Evonik Share

Further Information

Company

Events & Presentations

Here you will find dates, information and presentations on our events. ... MORE

Company

Analysts' estimates

Evonik Industries AG is covered by German and international financial analysts, who provide their own research analyses and earnings estimates in respect of the company. ... MORE

Company

News & Reports

Here you can find "Investor Relations News" with the latest news from our company, plus our most recent interim reports, annual reports and corporate responsibility reports. ... MORE

Reporting 2022/2023

March 2, 2023

Quarterly Report Q4 2022
May 9, 2023

Quarterly Report Q1 2023
August 10, 2023

Quarterly Report Q2 2023
November 7, 2023

Quarterly Report Q3 2023

Find current Events & Presentations here

Investor Relations

May 09, 2023

Weak economy characterizes difficult first quarter

Despite a difficult first quarter, Evonik confirms its earnings forecast for 2023. ... MORE

Investor Relations

May 04, 2023

Evonik expands global alkoxides business with new Singapore plant

Evonik has begun construction of a new production plant for alkoxides in Southeast Asia. ... MORE

Investor Relations

Apr 17, 2023

Pilot electrolysis plant in Herne: Green hydrogen for wind energy

Evonik is investing in a pilot electrolyzer at its site in Herne (Germany) to produce green hydrogen as a starting product for isophorone diamine (IPDA), a key raw material for rotor blades for wind turbines. ... MORE

Investor Relations

Apr 06, 2023

Evonik sells Lülsdorf site to ICIG - First step in the divestment of Performance Materials

Evonik is selling its site in Lülsdorf (Germany) and the associated cyanuric chloride business in Wesseling (Germany) to International Chemical Investors Group (ICIG, Luxembourg). ... MORE

Investor Relations

Apr 03, 2023

Evonik strengthens competitiveness of its Animal Nutrition business

Evonik is transforming the operating model of its Animal Nutrition business to further increase its customer focus, ensure competitiveness and enable further profitable growth. ... MORE

Investor Relations

Mar 02, 2023

Evonik delivers: Robust earnings in difficult environment

After a challenging year 2022, Evonik is cautiously optimistic for 2023. ... MORE

Further Information

Company

Financial data

Evonik is active in over 100 countries around the world. In fiscal 2018 more than 36,000 employees generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.6 billion. ... MORE

Company

Bonds & Rating

Evonik maintains a centralized approach to financing. Liabilities for credit and loans are fully guaranteed by Evonik Industries AG. ... MORE

Company

Key Figures Share

Here you find information about Evonik shares. ... MORE

Company

Contact & Service

You can find the contacts in the Investor Relations Department here. ... MORE

Company

Disclaimer

Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained. ... MORE

Company

Corporate Governance

As a globally active company, we have to comply with a wide range of statutory regulations and cultural standards. ... MORE

Investor Relations

Sustainable Investment (SRI)

We accept responsibility for our businesses, our employees, the environment and the society. ... MORE